Form 13-F position report

GOSSAMER BIO INC COM (DE)

Reported by Opaleye Management Inc

GOSS CUSIP 38341P102 Manager CIK 0001595855

Reported 2,982,200 shares, down 1,772,000 (37.3%) from the prior quarter.

Reported value -31.3%; share count -37.3% vs. the prior quarter.

Reduced
% of reported 13F value 0.72% This manager · Q4 2023
Shares 2,982,200 Quarter-end amount reported
Reported value $2,721,258 Fair value at quarter end
Consecutive quarters held 3 Through Q4 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-06-30 4044000
2023-09-30 3959298
2023-12-31 2721258
2024-03-31 2879329
2024-06-30 3522519
2024-09-30 3705692
2024-12-31 4061654
2025-03-31 4716157
2025-06-30 4360350
2025-09-30 7166750
2025-12-31 8432000
2026-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

12 quarters
Quarterly reported position history for GOSSAMER BIO INC COM (DE) held by Opaleye Management Inc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2026 Reduced 0 -2,720,000 (-100.0%) 0 $0 2026-05-15
Q4 2025 Reduced 2,720,000 -5,000 (-0.2%) 1.11% $8,432,000 2026-02-17
Q3 2025 Reduced 2,725,000 -820,000 (-23.1%) 1.01% $7,166,750 2025-11-14
Q2 2025 Reduced 3,545,000 -742,415 (-17.3%) 0.88% $4,360,350 2025-08-14
Q1 2025 Reduced 4,287,415 -202,585 (-4.5%) 1.05% $4,716,157 2025-05-15
Q4 2024 Added 4,490,000 +824,990 (22.5%) 0.71% $4,061,654 2025-02-14
Q3 2024 Reduced 3,665,010 -244,990 (-6.3%) 0.62% $3,705,692 2024-11-14
Q2 2024 Added 3,910,000 +1,469,891 (60.2%) 0.8% $3,522,519 2024-08-14
Q1 2024 Reduced 2,440,109 -542,091 (-18.2%) 0.63% $2,879,329 2024-05-15
Q4 2023 Reduced 2,982,200 -1,772,000 (-37.3%) 0.72% $2,721,258 2024-02-14
Q3 2023 Added 4,754,200 +1,384,200 (41.1%) 1.29% $3,959,298 2023-11-15
Q2 2023 New 3,370,000 +3,370,000 (0.0%) 0.97% $4,044,000 2023-08-14

Who else reported the position

118 managers reported GOSSAMER BIO INC COM (DE) for Q4 2023.

Managers reporting GOSSAMER BIO INC COM (DE) in Q4 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
NEA Management Company LLC Added 15,838,009 +110,067 0.96% $14,452,183 6 qtrs
FMR LLC Added 12,263,918 +11,625,497 < 0.01% $11,190,825 20 qtrs
Artal Group S A Added 12,058,968 +5,659,149 0.37% $11,004,000 20 qtrs
VANGUARD GROUP INC Added 11,635,634 +367,306 < 0.01% $10,617,516 20 qtrs
EcoR1 Capital LLC Unchanged 9,195,404 0 0.22% $8,390,806 2 qtrs
Octagon Capital Advisors LP Added 9,187,883 +1,000,000 1.34% $8,383,943 13 qtrs
ARCH Venture Management LLC Unchanged 8,055,916 0 4.5% $7,351,023 2 qtrs
Palo Alto Investors LP Reduced 5,958,888 -571,400 0.59% $6,530,288 15 qtrs
PLATINUM INVESTMENT MANAGEMENT LTD Added 6,954,110 +1,596,332 0.26% $6,345,625 4 qtrs
Eversept Partners LP Added 6,432,715 +2,004,858 0.52% $5,869,852 10 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2023
Filed
February 14, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
2,982,200
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.